Table 4.
Strain | Treatment | Length (mm)a
|
Cortical thickness (mm)b
|
Periosteal circumference (mm)a
|
|||
---|---|---|---|---|---|---|---|
Average | P value | Average | P value | Average | P value | ||
B6 | Control | 15.55 ± 0.09 | 0.062 | 0.200 ± 0.003 | 0.185 | 5.07 ± 0.03 | 0.002 |
Rosi | 15.32 ± 0.07 | 0.194 ± 0.003 | 4.93 ± 0.02 | ||||
C3H | Control | 15.75 ± 0.07 | 0.040 | 0.393 ± 0.008 | 0.013 | 4.77 ± 0.05 | 0.681 |
Rosi | 15.52 ± 0.08 | 0.363 ± 0.008 | 4.74 ± 0.05 | ||||
DBA | Control | 15.16 ± 0.08 | 0.265 | 0.243 ± 0.005 | 0.983 | 4.16 ± 0.04 | 0.841 |
Rosi | 15.29 ± 0.08 | 0.243 ± 0.004 | 4.17 ± 0.03 | ||||
A/J | Control | 15.28 ± 0.08 | 0.517 | 0.224 ± 0.007 | 0.296 | 4.28 ± 0.04 | 0.785 |
Rosi | 15.20 ± 0.08 | 0.213 ± 0.007 | 4.26 ± 0.04 | ||||
Strain × Rosi | 0.0331 | 0.0339 | 0.8553 |
Rosi, Rosiglitazone.
Body weight was a significant covariate for B6 only.
Body weight was a significant covariate for A/J only.